Waldemar

BlueNord: Tyra II Production Successfully Restarted

Retrieved on: 
금요일, 3월 22, 2024
Waldemar, DUC, Natural gas, Shell, Acquisition, Security (finance), Disclosure, European, ASA, TotalEnergies, LNG, Renewable energy

OSLO, Norway, March 22, 2024 /PRNewswire/ -- BlueNord ASA ("BlueNord" or the "Company") is pleased to announce that the Tyra Redevelopment Project ("Tyra" or "Tyra II") in the late hours on 21 March 2024 successfully reached an important milestone with the safe restart of production.

Key Points: 
  • OSLO, Norway, March 22, 2024 /PRNewswire/ -- BlueNord ASA ("BlueNord" or the "Company") is pleased to announce that the Tyra Redevelopment Project ("Tyra" or "Tyra II") in the late hours on 21 March 2024 successfully reached an important milestone with the safe restart of production.
  • With production from Tyra, Denmark will not only be self-sufficient but also a net-exporter of natural gas to Europe.
  • The production from the new Tyra facilities is expected to more than double BlueNord's net production to over 50 mboepd by the end of 2024 and unlock gross reserves of more than 200 mmboe.
  • I would like to thank TotalEnergies and the Tyra Project team for their commitment to the project and for safely restarting the production on Tyra.

Valdemar Family Opens Pintxo by Valdemar

Retrieved on: 
수요일, 9월 27, 2023
Restaurant, Bar, Wine & Spirits, Retail, Destinations, Travel, Waldemar, Wine, Friends, Sassafras, Olive oil, Multimedia, Lettuce, Cava, Water, Family, Glass, Bread, Baking, Wallington Cobblestone Schoolhouse District No. 8, Pincho, Gazpacho

Today, Jesús Martínez Bujanda, CEO of Valdemar Family , Bodegas Valdemar in Rioja, Spain, and Valdemar Estates in Walla Walla, Washington, announced the opening of Pintxo by Valdemar , a tapas, cocktail, and wine bar in Woodinville's Schoolhouse District (17409 133rd Ave NE, #1203).

Key Points: 
  • Today, Jesús Martínez Bujanda, CEO of Valdemar Family , Bodegas Valdemar in Rioja, Spain, and Valdemar Estates in Walla Walla, Washington, announced the opening of Pintxo by Valdemar , a tapas, cocktail, and wine bar in Woodinville's Schoolhouse District (17409 133rd Ave NE, #1203).
  • View the full release here: https://www.businesswire.com/news/home/20230927010119/en/
    Opened by the Valdemar Family, Pintxo by Valdemar is a new tapas, wine, and cocktail bar in Woodinville, WA.
  • Valdemar Club members who visit Pintxo by Valdemar, can expect exclusive touches that will enrich their visit.
  • A separate retail section sells imported Spanish items and wine from Valdemar Family's two properties, Bodegas Valdemar and Valdemar Estates.

Lymphoma Research Foundation to Honor Esteemed Lymphoma Physician Kara Kelly, MD at Annual Gala on September 28

Retrieved on: 
수요일, 8월 2, 2023
Lymphoma, SAB, University, Pediatrics, Therapy, Senior, Jacobs School of Medicine and Biomedical Sciences, Bone marrow, American Biographical Institute, John R. Oishei Children's Hospital, Children's Oncology Group, Cancer, Buffalo buffalo Buffalo buffalo buffalo buffalo Buffalo buffalo, Buffalo, Research, Roswell Park, Biomedical sciences, Young adult, Hodgkin, Waldemar, LRF, MD, Patient, Division, American Society of Pediatric Hematology/Oncology, Hospital, Leukemia, Health, Ziegfeld Theatre (1969), Pharmaceutical industry, Nursing, Genmab

NEW YORK, Aug. 2, 2023 /PRNewswire-PRWeb/ -- The Lymphoma Research Foundation (LRF), the nation's largest non-profit organization dedicated exclusively to funding innovative lymphoma research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives, and patient services, will host its 2023 Annual Gala on Thursday, September 28, at the Ziegfeld Ballroom in New York City.

Key Points: 
  • Genmab will be presented with the Lymphoma Research Foundation's Corporate Leadership Award for excellence in development of differentiated antibody therapeutics.
  • Honored at this year's gala will be LRF Scientific Advisory Board (SAB) member Kara Kelly, MD, who will recieve LRF's Distinguished Leadership Award.
  • "I am so incredibly honored to be receiving the Distinguished Leadership Award from the Lymphoma Research Foundation.'
  • We are proud to support the important work of the Lymphoma Research Foundation in achieving our shared goals for patients."

WPD Pharmaceuticals Welcome Dr. Waldemar Debinski to its Scientific Advisory Board

Retrieved on: 
수요일, 4월 1, 2020
Waldemar

VANCOUVER, British Columbia, April 01, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the Company or WPD) a clinical stage pharmaceutical company, is excited to announce that Dr. Waldemar Debinski, inventor of WPD101, WPD102 and WPD103 drug candidates has joined its Scientific Advisory Board.

Key Points: 
  • VANCOUVER, British Columbia, April 01, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the Company or WPD) a clinical stage pharmaceutical company, is excited to announce that Dr. Waldemar Debinski, inventor of WPD101, WPD102 and WPD103 drug candidates has joined its Scientific Advisory Board.
  • The Companys name comes from the names of inventors Dr. Waldemar Priebe and Dr. Waldemar Debinski, which creates the WPD in WPD Pharmaceuticals.
  • Mariusz Olejniczak, CEO of WPD commented, Not only is Dr. Debinski an exceptional scientist, hes also the inventor of WPD101, WPD102 and WPD103 drug candidates of the WPD portfolio, and we are thrilled to welcome him to our scientific advisory board.
  • The sublicense territory from CNS Pharmaceuticals and Moleculin Biotech includes 31 countries in Europe and Asia, including Russia.